Researchers have found that a novel drug combination disrupts multiple factors in an aggressive type of breast cancer.
Physician attitudes and patient expectations are driving overtreatment in older breast cancer patients. A new U-M study examines why the practice persists.
Surgeon attitudes were the biggest driver of likelihood that patients receive contralateral prophylactic mastectomy, a new study finds.
Researchers have developed a fluidic device to track over time which cancer cells lead the disease’s invasive march.
Cancer progression can be spurred by TGF-beta pathway signaling, and Michigan Medicine researchers have found a way to stop the signal from turning green.
Worry about recurrence and radiation more often lead women to weigh double mastectomy.